These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9382456)

  • 1. Correlation between morphologic and nonmorphologic prognostic markers of neuroblastoma.
    Joshi VV; Tsongalis GJ
    Ann N Y Acad Sci; 1997 Sep; 824():71-83. PubMed ID: 9382456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between morphologic and other prognostic markers of neuroblastoma. A study of histologic grade, DNA index, N-myc gene copy number, and lactic dehydrogenase in patients in the Pediatric Oncology Group.
    Joshi VV; Cantor AB; Brodeur GM; Look AT; Shuster JJ; Altshuler G; Larkin EW; Holbrook CT; Silverman JF; Norris HT
    Cancer; 1993 May; 71(10):3173-81. PubMed ID: 8490848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of modified Shimada classification with MYCN and 1p36 status detected by fluorescence in situ hybridization in neuroblastoma.
    Altungoz O; Aygun N; Tumer S; Ozer E; Olgun N; Sakizli M
    Cancer Genet Cytogenet; 2007 Jan; 172(2):113-9. PubMed ID: 17213019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.
    Shimada H; Stram DO; Chatten J; Joshi VV; Hachitanda Y; Brodeur GM; Lukens JN; Matthay KK; Seeger RC
    J Natl Cancer Inst; 1995 Oct; 87(19):1470-6. PubMed ID: 7674334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [N-myc gene copies in children with neuroblastoma and its clinical significance].
    Ma XL; Gong LP; Zhou CJ; Zhang DW; Jin M; Wang HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1447-51. PubMed ID: 23257451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma.
    Norris MD; Bordow SB; Marshall GM; Haber PS; Cohn SL; Haber M
    N Engl J Med; 1996 Jan; 334(4):231-8. PubMed ID: 8532000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma.
    Meitar D; Crawford SE; Rademaker AW; Cohn SL
    J Clin Oncol; 1996 Feb; 14(2):405-14. PubMed ID: 8636750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
    Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
    J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
    Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H
    Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified histologic grading of neuroblastomas by replacement of mitotic rate with mitosis karyorrhexis index. A clinicopathologic study of 223 cases from the Pediatric Oncology Group.
    Joshi VV; Rao PV; Cantor AB; Altshuler G; Shuster JJ; Castleberry RP
    Cancer; 1996 Apr; 77(8):1582-8. PubMed ID: 8608547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relationship Between Apoptotic Activity and Prognostic Factors in Neuroblastomas.
    Ekmekci S; Olgun N; Özer E
    Turk Patoloji Derg; 2016; 32(2):99-104. PubMed ID: 27136108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between histopathological features, MYCN amplification, and prognosis: a UKCCSG study. United Kingdom Children Cancer Study Group.
    George RE; Variend S; Cullinane C; Cotterill SJ; McGuckin AG; Ellershaw C; Lunec J; Pearson AD;
    Med Pediatr Oncol; 2001 Jan; 36(1):169-76. PubMed ID: 11464876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The International Neuroblastoma Pathology Classification (the Shimada system).
    Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B; Stram DO; Gerbing RB; Lukens JN; Matthay KK; Castleberry RP
    Cancer; 1999 Jul; 86(2):364-72. PubMed ID: 10421273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas.
    Combaret V; Gross N; Lasset C; Frappaz D; Peruisseau G; Philip T; Beck D; Favrot MC
    J Clin Oncol; 1996 Jan; 14(1):25-34. PubMed ID: 8558206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
    Nakagawara A; Arima-Nakagawara M; Scavarda NJ; Azar CG; Cantor AB; Brodeur GM
    N Engl J Med; 1993 Mar; 328(12):847-54. PubMed ID: 8441429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic clinical markers of human neuroblastoma with special reference to N-myc oncogene: amplified or not amplified?--An overview.
    Tsuchida Y; Hemmi H; Inoue A; Obana K; Yang HW; Hayashi Y; Kanda N; Shimatake H
    Tumour Biol; 1996; 17(2):65-74. PubMed ID: 8658015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of unfavorable histology, MYCN amplification and diploidy for stage I and II neuroblastomas.
    de Buys Roessingh AS; Rougemont AL; Wiesenauer C; Barrette S; Bouron-Dal Soglio D; Lallier M
    Eur J Pediatr Surg; 2008 Dec; 18(6):410-4. PubMed ID: 19012235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
    Krajewski S; Chatten J; Hanada M; Reed JC
    Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma.
    Cohn SL; Rademaker AW; Salwen HR; Franklin WA; Gonzales-Crussi F; Rosen ST; Bauer KD
    Am J Pathol; 1990 May; 136(5):1043-52. PubMed ID: 2349963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphologic features of neuroblastoma (Schwannian stroma-poor tumors) in clinically favorable and unfavorable groups.
    Ambros IM; Hata J; Joshi VV; Roald B; Dehner LP; Tüchler H; Pötschger U; Shimada H
    Cancer; 2002 Mar; 94(5):1574-83. PubMed ID: 11920516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.